Could cause temporary or reversible harm; serious harm is unlikely.
Labeling: Incorrect Instructions:outer carton contains the incorrect instructions for Step 2 stating "Do cut the patch" rather than the correct instructions of "Do not cut the patch". The pouch containing the patch is labeled correctly.
| Distributed by / for | Sandoz Inc |
| NDC | 66758-208-58 |
| Full product label | Transderm Scop (scopolamine) Transdermal System, 1.5 mg, 1 patch per pouch (NDC 66758-208-58), packaged in 4-count patches per carton (NDC 66758-208-54), Rx Only, Manufactured by ALZA Corporation, Vacaville, CA 95688 for Sandoz Inc., Princeton, NJ 08540. |
| Recalling firm | Sandoz Inc |
| Distribution | Nationwide in the USA and Puerto Rico |
| Quantity | 157,922 cartons |
| Recall initiated | 2017-02-02 |
| Report date | 2017-03-01 |
| Recall completed | 2017-10-24 |
| Recall number | D-0481-2017 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Princeton NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗